Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2001
10/17/2001EP1144685A2 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
10/17/2001EP1144684A2 Enhanced sequencing by hybridization using pools of probes
10/17/2001EP1144626A2 Methods of monitoring hiv drug resistance
10/17/2001EP1144609A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof
10/17/2001EP1144429A2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/17/2001EP1144414A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/17/2001EP1144106A2 Device for carrying out chemical reactions
10/17/2001EP1143980A1 Thio-modified aptamer synthetic methods and compositions
10/17/2001EP0901501B1 Nucleoside derivatives with photo-unstable protective groups
10/17/2001EP0832244A4 Polyphenol oxidase genes from lettuce and banana
10/17/2001CN1073160C Method for sensitive detection of nuceic acids
10/17/2001CN1073154C Superoxide dismutase-4
10/16/2001US6303799 Polynucleotide crosslinking agents
10/16/2001US6303775 Polynucleotides labelled with asymmetric benzoxanthene dyes
10/16/2001US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis
10/16/2001US6303376 Stimulation using cellular dna synthesis or repair mechanisms
10/16/2001US6303328 Anticarcinogenic agents
10/16/2001US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection
10/16/2001US6303307 Large scale genotyping of disease and a diagnostic test for spinocerebellar ataxia type 6
10/16/2001US6303305 Method for quantification of an analyte
10/16/2001CA2044626C Type a platelet-derived growth factor receptor gene
10/16/2001CA2036946C Indexing linkers
10/16/2001CA1341305C Dna binding proteins including androgen receptor
10/11/2001WO2001075175A2 Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility
10/11/2001WO2001075164A2 Rna sequence-specific mediators of rna interference
10/11/2001WO2001075139A1 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization
10/11/2001WO2001075082A1 DEOXYRIBONUCLEASE IIβ PROTEINS AND cDNAs
10/11/2001WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001WO2001075067A2 Novel nucleic acids and polypeptides
10/11/2001WO2001074845A2 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
10/11/2001WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001WO2001048190A8 Therapeutic uses of lna-modified oligonucleotides
10/11/2001US20010029296 Minimization of blooming in high-density arrays by using reactive wash reagents
10/11/2001US20010029250 Antiinflammatory agents; anticarcinogenic agents
10/11/2001US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase
10/11/2001US20010029028 Method and apparatus for combinatorial chemistry
10/11/2001US20010029021 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma
10/11/2001US20010028866 Chemical synthesis apparatus employing a droplet generator
10/11/2001CA2404890A1 Rna sequence-specific mediators of rna interference
10/11/2001CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/10/2001EP1142902A2 3'-Derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use
10/10/2001EP1142591A1 Gene carriers
10/10/2001EP1141718A1 Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces
10/10/2001EP1141409A1 A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis
10/10/2001EP1141399A1 Sequencing method using magnifying tags
10/10/2001EP1141394A1 Nucleic acid sequencing method
10/10/2001EP1141385A2 Target molecule attachment to surfaces
10/10/2001EP1141137A1 Water-soluble rhodamine dyes and conjugates thereof
10/10/2001EP1140967A1 Targeted gene transfer using g protein coupled receptors
10/10/2001EP1140966A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
10/10/2001EP1140965A1 Protonated/acidified nucleic acids and methods of use
10/10/2001EP1140963A2 Functionalised polynucleotide compound, optionally marked and method for detecting a target nucleic acid
10/10/2001EP1140736A2 Polymer arrays and methods of making and using same
10/10/2001EP1140312A1 Methods and apparatus for processing temperature sensitive materials
10/10/2001CN1317050A Nucleotide sequences which code for the tal gene
10/10/2001CN1316515A Human liver cancer related cancer suppressing protein and its coding sequence
10/10/2001CN1072719C Isolated nucleic acid sequence coding for tumor rejection antigen precursor
10/09/2001US6300491 Antisense nucleotide for the treatment of allograft defects, cancers and metastasis, inflammatory bowel disease, psoriasis and skin disorders
10/09/2001US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers
10/09/2001US6300486 Condensing a nucleoside having one hydroxyl end bearing a h-phosphonate group and the other protected with polymer-bound nucleoside having free hydroxyl end in solvent which swells polymer, deprotecting, repeating, oxidation
10/09/2001US6300320 Modulation of c-jun using inhibitors of protein kinase C
10/09/2001US6300310 Amino acid sequence with segments of polypeptides
10/09/2001US6300137 Method for synthesizing a specific, surface-bound polymer uniformly over an element of a molecular array
10/09/2001US6300119 Stretococcal ERS
10/09/2001US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins
10/09/2001US6300074 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
10/09/2001US6300063 Polymorphism detection
10/09/2001US6300058 Immobilize a polynucleotide to an insoluble support, allow hybridization to a unique mrna sequence, apply a second probe to the support that hybridizes to a second sequence of the mrna, measure immobilization to quantitate mrna
10/09/2001US6300056 A synthetic oligonulceotide having one segment homologous with a segment of hiv nucleic acid and a second segment of a nucleotide sequence which is homologous to an oligonucleotide segment of a nucleic acid multimer not complementary to hiv
10/09/2001US6299881 Mixing uronium salt reagent with soluble first moiety selected from polysaccharides and carbohydrates, mixing second moiety with first moiety, wherein second moiety is selected from proteins, peptides, lipoproteins, haptens, carbohydrates
10/09/2001US6299876 Cytotoxic drug therapy
10/09/2001CA1341302C Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
10/09/2001CA1341301C Preparation of functional human urokinase proteins
10/09/2001CA1341300C Recombinant dna means and method for producing bovine rennin and precursors
10/04/2001WO2001073130A1 Diagnostic polymorphisms of tgf-beta1 promoter
10/04/2001WO2001073125A2 High throughput screening array containing porous material
10/04/2001WO2001073123A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/04/2001WO2001072926A1 Trityl-type compounds and their use
10/04/2001WO2001072766A1 Quality control reagents for nucleic acid microarrays
10/04/2001WO2001072765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
10/04/2001WO2001072764A1 N?8- and c8¿-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotide hybridization
10/04/2001WO2001020017A3 Metal cluster containing nucleotides and nucleic acids, and intermediates therefor
10/04/2001WO2001016369A3 Uv excitable fluorescent energy transfer dyes
10/04/2001WO2000043515A3 Methods of monitoring hiv drug resistance
10/04/2001US20010027251 Mimic or modulate activity of wild-type nucleic acids thereby affecting protein production or activity
10/04/2001US20010027187 Such as hydroxyethylated bis(trimethoxysilylpropyl)amine as well as modified polyamines for use as silylating agents in surface treatment of silica and in formation of nucleic acid arrays
10/04/2001US20010026935 First and second column select transistors, the column select transistors being adapted for control by column selector, first and second row select transistors, being adapted for control by row selector, output connected to node
10/04/2001US20010026921 Solid matrix with a intercalator capable of binding DNA, RNA, or DNA-RNA hybrid, a intercalator fluorophore acting as energy acceptor or donator, and a oligo- or polynucleotide probe with a lanthanide metal chelate bound to it
10/04/2001US20010026918 Reducing background signals; accuracy
10/04/2001US20010026917 DNA detection device
10/04/2001US20010026915 Spectral changes in biopolymer
10/04/2001US20010026778 Systems and methods for the active electronic control of biological reactions
10/04/2001EP1138689A1 N8- and C8-linked purine bases as universal nucleosides used for oligonucleotide hybridization
10/04/2001EP1138688A1 N8- and C8- linked purine bases as universal nucleosides used for oligonucleotide hybridization
10/04/2001EP1137812A1 Dna-protein fusions and uses thereof
10/04/2001EP1137785A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE
10/04/2001DE19955361A1 Verfahren zur Herstellung konfektionierter chemischer Oberflächen Process for the preparation of chemical-assembled surfaces
10/04/2001CA2403911A1 Quality control reagents for nucleic acid microarrays
10/04/2001CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing
10/03/2001CN1315453A Polypeptide-human formin protein 11 and polynucleotide for coding it